E-Posters-10223

10223_Mueller

Pdf Summary

The study aimed to assess sexual satisfaction and function in heterosexual couples following treatment for urgency urinary incontinence (UUI) in the female partner. The study, called the Incontinence and IntiMate Partners Clinical Trial (iIMPACT), enrolled female patients seeking treatment for UUI who were undergoing solifenacin treatment and had a male partner willing to participate. Both partners completed the Golombok-Rust Inventory of Sexual Satisfaction (GRISS) at baseline and at the end of the three-month treatment period. Female solifenacin treatment responders reported improvements in the number of times sexual intercourse took place, as well as decreases in urinary distress and improvements in overall sexual satisfaction. However, male partners did not report any changes in sexual satisfaction. Thirty-one percent of women were classified as solifenacin treatment responders, with 25% of them requiring a dosage increase. There were no differences in demographic or physical characteristics between responders and non-responders, except that most responders were under 60 years old. The study included 51 out of 65 enrolled couples, with an average age of 59 for females and 60 for males. The majority of the couples were Caucasian and in a relationship for an average of 30 years. Overall, the study suggests that solifenacin treatment for UUI can lead to improvements in sexual satisfaction for female patients, but no significant changes were reported by male partners.

Keywords

sexual satisfaction

heterosexual couples

urgency urinary incontinence

solifenacin treatment

GRISS

improvements

treatment responders

dosage increase

demographic characteristics

male partners